# Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)

> **NCT04083846** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 24 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** Reference drug
- **DRUG:** Test drug 1
- **DRUG:** Test drug 2

## Key facts

- **NCT ID:** NCT04083846
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-06
- **Primary completion:** 2019-10-21
- **Final completion:** 2019-10-25
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04083846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04083846, "Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04083846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*